marketcaparena
Search

    TMDX

    TransMedics Group, Inc.

    Company overview

    Market capitalization
    $2.87B
    Employees
    898
    Latest publication
    2026-09-29
    About TransMedics Group, Inc.

    TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue189,948,000USD173,933,000USD160,764,000USD143,823,000USD157,370,000USD143,537,000USD121,624,000USD108,761,000USD
    Cost Of Revenue76,750,000USD72,772,000USD67,350,000USD59,248,000USD60,781,000USD55,309,000USD49,611,000USD47,916,000USD
    Gross Profit113,198,000USD101,161,000USD93,414,000USD84,575,000USD96,589,000USD88,228,000USD72,013,000USD60,845,000USD
    Research Development31,632,000USD24,879,000USD20,701,000USD15,260,000USD15,934,000USD17,160,000USD16,464,000USD14,266,000USD
    Selling General Administrative57,830,000USD55,654,000USD50,175,000USD44,939,000USD44,088,000USD43,625,000USD46,905,000USD42,656,000USD
    Total Operating Expenses89,462,000USD87,864,000USD72,141,000USD61,275,000USD60,022,000USD60,785,000USD63,369,000USD56,922,000USD
    Operating Income23,736,000USD13,297,000USD21,273,000USD23,300,000USD36,567,000USD27,443,000USD8,644,000USD3,923,000USD
    Total Other Income Expense Net-4,331,000USD-4,812,000USD360,000USD-269,000USD-385,000USD-767,000USD-1,655,000USD322,000USD
    Interest Expense7,225,000USD7,170,000USD3,354,000USD3,491,000USD3,476,000USD3,461,000USD3,571,000USD3,617,000USD
    Income Before Tax19,405,000USD8,485,000USD21,633,000USD23,031,000USD36,182,000USD26,676,000USD6,989,000USD4,245,000USD
    Income Tax Expense4,723,000USD1,170,000USD-83,750,000USD-1,288,000USD1,275,000USD994,000USD132,000USD29,000USD
    Net Income14,682,000USD7,315,000USD105,383,000USD24,319,000USD34,907,000USD25,682,000USD6,857,000USD4,216,000USD
    Selling And Marketing Expenses—1,269,000USD1,265,000USD1,076,000USD———200,000USD
    Unclassified Operating Expenses—6,062,000USD——————
    Net Interest Income—-7,170,000USD-11,454,000USD-191,000USD-976,000USD-3,461,000USD-14,071,000USD-317,000USD
    Tax Provision—1,170,000USD-83,750,000USD-1,288,000USD1,275,000USD994,000USD132,000USD29,000USD
    Net Income From Continuing Ops—7,315,000USD105,383,000USD24,319,000USD34,907,000USD25,682,000USD6,857,000USD4,216,000USD
    Ebit—15,655,000USD24,987,000USD26,522,000USD39,658,000USD30,137,000USD10,560,000USD7,862,000USD
    Ebitda—27,519,000USD32,455,000USD33,371,000USD46,389,000USD36,274,000USD16,240,000USD13,039,000USD
    Depreciation And Amortization—11,864,000USD7,468,000USD6,849,000USD6,731,000USD6,137,000USD5,680,000USD5,177,000USD
    Reconciled Depreciation—11,864,000USD7,468,000USD6,849,000USD6,731,000USD6,137,000USD5,680,000USD5,177,000USD
    Interest Income———3,300,000USD2,500,000USD——3,300,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20062006-12-31 · USD
    Total Revenue605,494,000USD441,540,000USD—
    Cost Of Revenue242,688,000USD179,459,000USD—
    Gross Profit362,806,000USD262,081,000USD—
    Research Development69,055,000USD55,968,000USD13,645,000USD
    Selling General Administrative180,852,000USD168,617,000USD4,599,000USD
    Selling And Marketing Expenses4,316,000USD——
    Total Operating Expenses254,223,000USD224,585,000USD18,244,000USD
    Operating Income108,583,000USD37,496,000USD-18,244,000USD
    Interest Expense13,782,000USD14,409,000USD0USD
    Net Interest Income-13,782,000USD-14,409,000USD—
    Income Before Tax107,522,000USD35,780,000USD-17,554,000USD
    Income Tax Expense-82,769,000USD316,000USD—
    Tax Provision-82,769,000USD316,000USD—
    Net Income190,291,000USD35,464,000USD-17,554,000USD
    Net Income From Continuing Ops190,291,000USD35,464,000USD-17,554,000USD
    Ebit121,304,000USD50,189,000USD-18,244,000USD
    Ebitda148,489,000USD69,947,000USD—
    Depreciation And Amortization27,185,000USD19,758,000USD—
    Reconciled Depreciation27,185,000USD19,758,000USD—
    Total Other Income Expense Net-1,061,000USD-1,716,000USD690,000USD
    Net Income Applicable To Common Shares——-21,932,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets1,464,396,000USD1,434,820,000USD1,068,373,000USD946,032,000USD890,522,000USD837,530,000USD804,076,000USD785,571,000USD
    Total Current Assets651,124,000USD619,280,000USD637,783,000USD612,996,000USD558,129,000USD505,918,000USD497,216,000USD492,475,000USD
    Other Current Assets20,174,000USD16,924,000USD16,254,000USD21,614,000USD13,835,000USD10,369,000USD16,290,000USD20,101,000USD
    Other Non Current Assets2,188,000USD———————
    Total Liabilities946,343,000USD———————
    Total Current Liabilities98,283,000USD91,920,000USD89,305,000USD79,721,000USD56,620,000USD55,603,000USD59,913,000USD60,048,000USD
    Total Stockholder Equity518,053,000USD494,007,000USD473,100,000USD355,200,000USD318,101,000USD266,308,000USD228,603,000USD209,920,000USD
    Total Equity Including Noncontrolling Interest518,053,000USD———————
    Short Long Term Debt20,000,000USD15,000,000USD10,000,000USD5,000,000USD————
    Deferred Revenue3,130,000USD———————
    Net Receivables104,138,000USD90,727,000USD84,282,000USD80,702,000USD104,851,000USD142,026,000USD97,722,000USD90,128,000USD
    Inventory54,137,000USD49,890,000USD48,881,000USD44,506,000USD38,868,000USD43,380,000USD46,554,000USD52,152,000USD
    Property Plant Equipment Net369,948,000USD700,974,000USD332,811,000USD318,762,000USD318,073,000USD317,251,000USD292,451,000USD278,682,000USD
    Goodwill11,549,000USD———————
    Intangible Assets0USD—1,948,000USD1,999,000USD2,050,000USD2,101,000USD2,152,000USD2,202,000USD
    Accounts Payable12,909,000USD11,151,000USD10,350,000USD12,162,000USD9,539,000USD10,595,000USD10,292,000USD13,134,000USD
    Short Term Debt3,646,000USD18,508,000USD13,310,000USD8,238,000USD3,021,000USD2,791,000USD2,727,000USD5,086,000USD
    Common Stock774,216,000USD764,640,000USD750,926,000USD738,432,000USD725,655,000USD709,194,000USD697,208,000USD685,251,000USD
    Retained Earnings-255,953,000USD-270,635,000USD-277,950,000USD-383,333,000USD-407,652,000USD-442,559,000USD-468,241,000USD-475,098,000USD
    Accumulated Other Comprehensive Income-210,000USD2,000USD124,000USD101,000USD98,000USD-327,000USD-364,000USD-233,000USD
    Total Liab—940,813,000USD595,273,000USD590,832,000USD572,421,000USD571,222,000USD575,473,000USD575,651,000USD
    Other Current Liab—59,316,000USD62,740,000USD56,016,000USD42,490,000USD40,139,000USD45,152,000USD39,644,000USD
    Capital Stock—764,640,000USD750,926,000USD738,432,000USD725,655,000USD709,194,000USD697,208,000USD685,251,000USD
    Good Will—11,549,000USD11,549,000USD11,549,000USD11,549,000USD11,549,000USD11,549,000USD11,549,000USD
    Cash—461,739,000USD488,366,000USD466,174,000USD400,575,000USD310,143,000USD336,650,000USD330,094,000USD
    Cash And Short Term Investments—461,739,000USD488,366,000USD466,174,000USD400,575,000USD310,143,000USD336,650,000USD330,094,000USD
    Current Deferred Revenue—2,945,000USD2,905,000USD3,305,000USD1,570,000USD2,078,000USD1,742,000USD2,184,000USD
    Net Debt—401,676,000USD-18,675,000USD53,175,000USD118,247,000USD208,267,000USD181,637,000USD188,052,000USD
    Short Long Term Debt Total—863,415,000USD469,691,000USD519,349,000USD518,822,000USD518,410,000USD518,287,000USD518,146,000USD
    Long Term Debt—498,195,000USD502,391,000USD506,685,000USD510,889,000USD510,098,000USD509,311,000USD508,531,000USD
    Property Plant Equipment Gross—774,796,000USD398,876,000USD379,340,000USD371,850,000USD364,142,000USD333,165,000USD313,922,000USD
    Common Stock Shares Outstanding—36,194,023shares40,927,898shares40,748,023shares40,558,953shares39,914,000shares35,211,121shares35,683,952shares
    Non Current Assets Total—815,540,000USD430,590,000USD333,036,000USD332,393,000USD331,612,000USD306,860,000USD293,096,000USD
    Non Current Liabilities Total—848,893,000USD505,968,000USD511,111,000USD515,801,000USD515,619,000USD515,560,000USD515,603,000USD
    Non Current Liabilities Other—3,986,000USD——————
    Non Currrent Assets Other—20,541,000USD739,000USD726,000USD721,000USD711,000USD708,000USD663,000USD
    Net Working Capital—527,360,000USD548,478,000USD533,275,000USD501,509,000USD450,315,000USD437,303,000USD432,427,000USD
    Unclassified Non Current Assets—82,476,000USD83,543,000USD—————
    Unclassified Current Liabilities—-15,000,000USD-10,000,000USD-5,000,000USD————
    Unclassified Non Current Liabilities—346,712,000USD———5,521,000USD6,249,000USD7,072,000USD
    Unclassified Equity—-764,640,000USD-750,926,000USD-738,432,000USD-725,655,000USD-709,194,000USD-697,208,000USD-685,251,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets1,068,373,000USD804,076,000USD706,047,000USD277,147,000USD134,893,000USD152,026,000USD105,299,000USD42,157,000USD
    Intangible Assets1,948,000USD2,152,000USD2,354,000USD—————
    Other Current Assets16,254,000USD16,290,000USD8,031,000USD2,896,000USD5,460,000USD2,326,000USD1,538,000USD1,838,000USD
    Total Liab595,273,000USD575,473,000USD568,845,000USD89,772,000USD67,039,000USD48,135,000USD50,650,000USD46,982,000USD
    Total Stockholder Equity473,100,000USD228,603,000USD137,202,000USD187,375,000USD67,854,000USD103,891,000USD54,649,000USD-4,825,000USD
    Other Current Liab62,740,000USD45,152,000USD38,221,000USD18,635,000USD16,337,000USD10,410,000USD8,702,000USD7,833,000USD
    Common Stock750,926,000USD697,208,000USD641,106,000USD666,277,000USD510,488,000USD502,217,000USD424,134,000USD331,212,000USD
    Capital Stock750,926,000USD697,208,000USD641,106,000USD666,277,000USD510,488,000USD502,217,000USD424,134,000USD331,212,000USD
    Retained Earnings-277,950,000USD-468,241,000USD-503,705,000USD-478,677,000USD-442,446,000USD-398,231,000USD-369,483,000USD-335,936,000USD
    Good Will11,549,000USD11,549,000USD11,990,000USD0USD————
    Cash488,366,000USD336,650,000USD394,812,000USD201,182,000USD25,580,000USD24,581,000USD20,092,000USD20,241,000USD
    Cash And Short Term Investments488,366,000USD336,650,000USD394,812,000USD201,182,000USD92,452,000USD125,642,000USD80,688,000USD20,241,000USD
    Total Current Assets637,783,000USD497,216,000USD510,654,000USD252,294,000USD118,705,000USD146,766,000USD100,001,000USD34,794,000USD
    Total Current Liabilities89,305,000USD59,913,000USD54,934,000USD23,661,000USD23,238,000USD11,879,000USD16,115,000USD12,553,000USD
    Current Deferred Revenue2,905,000USD1,742,000USD1,961,000USD241,000USD250,000USD263,000USD166,000USD306,000USD
    Net Debt-18,675,000USD181,637,000USD121,134,000USD-133,627,000USD-16,976,000USD10,076,000USD14,054,000USD13,429,000USD
    Short Term Debt13,310,000USD2,727,000USD2,035,000USD1,444,000USD8,604,000USD———
    Short Long Term Debt10,000,000USD———————
    Short Long Term Debt Total469,691,000USD518,287,000USD515,946,000USD67,555,000USD43,801,000USD34,657,000USD34,146,000USD33,670,000USD
    Long Term Debt502,391,000USD509,311,000USD506,204,000USD58,696,000USD35,197,000USD34,657,000USD34,146,000USD33,670,000USD
    Net Receivables84,282,000USD97,722,000USD63,576,000USD27,611,000USD5,934,000USD6,864,000USD6,559,000USD3,438,000USD
    Inventory48,881,000USD46,554,000USD44,235,000USD20,605,000USD14,859,000USD11,934,000USD11,216,000USD9,277,000USD
    Accounts Payable10,350,000USD10,292,000USD12,717,000USD3,341,000USD6,651,000USD1,206,000USD7,247,000USD4,720,000USD
    Property Plant Equipment Net332,811,000USD292,451,000USD180,487,000USD24,353,000USD15,688,000USD4,754,000USD4,792,000USD3,474,000USD
    Property Plant Equipment Gross398,876,000USD333,165,000USD201,780,000USD24,353,000USD15,688,000USD4,754,000USD4,792,000USD3,474,000USD
    Accumulated Other Comprehensive Income124,000USD-364,000USD-199,000USD-225,000USD-188,000USD-95,000USD-2,000USD-101,000USD
    Common Stock Shares Outstanding40,540,694shares35,217,000shares32,517,372shares29,556,633shares27,616,839shares24,702,764shares14,204,787shares19,246,097shares
    Non Current Assets Total430,590,000USD306,860,000USD195,393,000USD24,853,000USD16,188,000USD5,260,000USD5,298,000USD7,363,000USD
    Non Current Liabilities Total505,968,000USD515,560,000USD513,911,000USD66,111,000USD43,801,000USD36,256,000USD34,535,000USD34,429,000USD
    Non Currrent Assets Other739,000USD708,000USD562,000USD500,000USD500,000USD506,000USD6,000USD3,389,000USD
    Net Working Capital548,478,000USD437,303,000USD455,720,000USD228,633,000USD95,467,000USD134,887,000USD83,886,000USD22,241,000USD
    Unclassified Non Current Assets83,543,000USD——————-3,389,000USD
    Unclassified Current Liabilities-10,000,000USD———-8,604,000USD———
    Unclassified Equity-750,926,000USD-697,208,000USD-641,106,000USD-666,277,000USD-510,488,000USD-502,217,000USD-424,134,000USD-331,212,000USD
    Unclassified Non Current Liabilities—6,249,000USD7,707,000USD7,415,000USD—-1,599,000USD—-3,383,000USD
    Other Assets———500,000USD500,000USD506,000USD506,000USD3,889,000USD
    Short Term Investments———0USD66,872,000USD101,061,000USD60,596,000USD0USD
    Net Tangible Assets———187,375,000USD67,854,000USD103,891,000USD54,649,000USD-192,242,000USD
    Non Current Liabilities Other————8,604,000USD———
    Deferred Long Term Liab—————1,599,000USD—3,383,000USD
    Other Liab—————1,599,000USD389,000USD759,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income7,315,000USD105,383,000USD24,319,000USD34,907,000USD25,682,000USD6,857,000USD4,216,000USD12,194,000USD
    Depreciation11,864,000USD7,468,000USD6,849,000USD6,731,000USD6,137,000USD5,680,000USD5,177,000USD4,599,000USD
    Stock Based Compensation9,952,000USD9,395,000USD9,136,000USD9,372,000USD8,958,000USD10,767,000USD7,944,000USD7,643,000USD
    Other Non Cash Items5,689,000USD751,000USD1,338,000USD414,000USD768,000USD2,191,000USD769,000USD1,105,000USD
    Change To Account Receivables-6,520,000USD-3,582,000USD24,148,000USD37,518,000USD-44,134,000USD-7,841,000USD-8,819,000USD757,000USD
    Change To Inventory-3,896,000USD-6,531,000USD-6,902,000USD3,714,000USD2,003,000USD4,136,999USD-4,558,000USD-2,319,000USD
    Change In Working Capital-11,354,000USD-4,941,000USD27,931,000USD40,185,000USD-44,400,000USD-5,832,000USD-11,249,000USD177,000USD
    Total Cash From Operating Activities24,533,000USD34,513,000USD69,573,000USD91,609,000USD-2,855,000USD19,663,000USD6,857,000USD25,718,000USD
    Capital Expenditures-36,657,000USD-15,514,000USD-7,624,000USD-9,075,000USD-27,038,000USD-13,606,000USD-48,203,000USD-23,763,000USD
    Free Cash Flow-12,124,000USD18,999,000USD61,949,000USD82,534,000USD-29,893,000USD6,057,000USD-41,346,000USD1,955,000USD
    Total Cashflows From Investing Activities-36,657,000USD-15,514,000USD-7,624,000USD-9,075,000USD-27,038,000USD-13,606,000USD-47,762,000USD-23,763,000USD
    Total Cash From Financing Activities3,762,000USD3,099,000USD3,641,000USD7,089,000USD3,028,000USD1,186,000USD7,862,000USD10,641,000USD
    Sale Purchase Of Stock1,688,000USD—1,963,000USD1,286,000USD——1,423,000USD—
    Change In Cash-8,689,000USD22,192,000USD65,599,000USD90,432,000USD-26,507,000USD6,556,000USD-32,657,000USD12,534,000USD
    Begin Period Cash Flow488,866,000USD466,674,000USD400,575,000USD310,643,000USD337,150,000USD330,594,000USD362,751,000USD350,217,000USD
    End Period Cash Flow480,177,000USD488,866,000USD466,174,000USD401,075,000USD310,643,000USD337,150,000USD330,094,000USD362,751,000USD
    Other Cashflows From Financing Activities-138,000USD3,099,000USD-138,000USD5,803,000USD3,028,000USD1,186,000USD7,862,000USD10,641,000USD
    Unclassified Operating Cash Flow1,067,000USD-83,543,000USD——————
    Unclassified Financing Cash Flow2,212,000USD—1,816,000USD———-1,423,000USD—
    Investments——-7,624,000USD-9,075,000USD-27,038,000USD-13,606,000USD-47,762,000USD-23,763,000USD
    Unclassified Investing Cash Flow——7,624,000USD9,075,000USD27,038,000USD13,606,000USD47,762,000USD23,763,000USD
    Net Borrowings—————0USD0USD—
    Other Cashflows From Investing Activities——————441,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income190,291,000USD35,464,000USD-25,028,000USD-36,231,000USD-44,215,000USD-28,748,000USD-33,547,000USD-23,756,000USD
    Depreciation27,185,000USD19,758,000USD8,177,000USD3,478,000USD1,817,000USD1,577,000USD1,222,000USD769,000USD
    Stock Based Compensation36,861,000USD33,224,000USD19,791,000USD10,321,000USD6,878,000USD2,414,000USD854,000USD144,000USD
    Other Non Cash Items4,795,000USD5,357,000USD30,039,000USD3,374,000USD3,653,000USD511,000USD475,000USD177,000USD
    Change To Account Receivables13,950,000USD-34,310,000USD-33,816,000USD-21,678,000USD840,000USD-218,000USD-3,166,000USD-2,513,000USD
    Change To Inventory-7,716,000USD-8,353,000USD-28,092,000USD-8,024,000USD-4,894,000USD-1,740,000USD-4,121,000USD-2,699,000USD
    Change In Working Capital17,251,000USD-45,000,000USD-44,347,000USD-26,759,000USD3,003,000USD-5,588,000USD-1,626,000USD-4,327,000USD
    Total Cash From Operating Activities192,840,000USD48,803,000USD-13,028,000USD-45,817,000USD-28,864,000USD-30,265,000USD-32,286,000USD-25,984,000USD
    Capital Expenditures-59,251,000USD-129,744,000USD-179,059,000USD-11,907,000USD-3,519,000USD-455,000USD-165,000USD-418,000USD
    Free Cash Flow133,589,000USD-80,941,000USD-192,087,000USD-57,724,000USD-32,383,000USD-30,720,000USD-32,451,000USD-26,402,000USD
    Total Cashflows From Investing Activities-59,251,000USD-129,303,000USD-193,953,000USD54,513,000USD29,267,000USD-41,598,000USD-60,501,000USD12,307,000USD
    Net Borrowings0USD0USD445,380,000USD22,459,000USD22,459,000USD22,459,000USD22,459,000USD24,360,000USD
    Total Cash From Financing Activities16,857,000USD22,874,000USD400,418,000USD167,927,000USD1,393,000USD75,549,000USD92,723,000USD22,064,000USD
    Sale Purchase Of Stock-138,000USD—955,000USD509,000USD419,000USD357,000USD202,000USD46,000USD
    Change In Cash151,716,000USD-58,162,000USD193,630,000USD175,602,000USD999,000USD4,489,000USD-149,000USD8,305,000USD
    Begin Period Cash Flow337,150,000USD395,312,000USD201,682,000USD26,080,000USD25,081,000USD20,592,000USD20,741,000USD12,436,000USD
    End Period Cash Flow488,866,000USD337,150,000USD395,312,000USD201,682,000USD26,080,000USD25,081,000USD20,592,000USD20,741,000USD
    Other Cashflows From Financing Activities16,995,000USD22,874,000USD-52,072,000USD5,614,000USD1,393,000USD2,128,000USD-4,644,000USD-2,296,000USD
    Unclassified Operating Cash Flow-83,543,000USD—-1,660,000USD————1,009,000USD
    Investments—-129,303,000USD-154,899,000USD54,513,000USD32,786,000USD-41,143,000USD-60,501,000USD12,725,000USD
    Issuance Of Capital Stock—0USD-160,000USD139,854,000USD0USD75,670,000USD97,367,000USD0USD
    Other Cashflows From Investing Activities—-129,744,000USD-27,212,000USD-107,000USD32,786,000USD-41,143,000USD-60,336,000USD12,725,000USD
    Unclassified Investing Cash Flow—259,488,000USD167,217,000USD12,014,000USD-32,786,000USD41,143,000USD60,501,000USD-12,725,000USD
    Dividends Paid——-51,117,000USD——-357,000USD——
    Unclassified Financing Cash Flow——57,272,000USD139,345,000USD-22,878,000USD50,962,000USD74,706,000USD—
    Change To Liabilities———-3,270,000USD9,965,000USD-5,742,000USD3,307,000USD231,000USD
    Cash And Cash Equivalents Changes————1,796,000USD———
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductProduct111,158,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductService Unrelated To OCSTransplant1,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductServices78,790,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductProduct107,972,000USD0001193125-26-206453
    Q1 2026Quarterly · 2026-03-31ProductService Unrelated To OCSTransplant1,300,000USD0001193125-26-206453
    Q1 2026Quarterly · 2026-03-31ProductServices65,961,000USD0001193125-26-206453
    Q4 2025Quarterly · 2025-12-31ProductProduct100,390,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductService Unrelated To OCSTransplant1,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductServices60,374,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductProduct372,401,000USD0001193125-26-067032
    FY 2025Yearly · 2025-12-31ProductService Unrelated To OCSTransplant4,100,000USD0001193125-26-067032
    FY 2025Yearly · 2025-12-31ProductServices233,093,000USD0001193125-26-067032
    Q3 2025Quarterly · 2025-09-30ProductProduct87,677,000USD0001193125-25-256377
    Q3 2025Quarterly · 2025-09-30ProductService Unrelated To OCSTransplant1,200,000USD0001193125-25-256377
    Q3 2025Quarterly · 2025-09-30ProductServices56,146,000USD0001193125-25-256377
    Q2 2025Quarterly · 2025-06-30ProductProduct96,100,000USD0000950170-25-100314
    Q2 2025Quarterly · 2025-06-30ProductService Unrelated To OCSTransplant1,000,000USD0000950170-25-100314
    Q2 2025Quarterly · 2025-06-30ProductServices61,270,000USD0000950170-25-100314
    Q1 2025Quarterly · 2025-03-31ProductProduct88,234,000USD0001193125-26-206453
    Q1 2025Quarterly · 2025-03-31ProductService Unrelated To OCSTransplant900,000USD0001193125-26-206453
    Q1 2025Quarterly · 2025-03-31ProductServices55,303,000USD0001193125-26-206453
    FY 2024Yearly · 2024-12-31ProductProduct273,866,000USD0001193125-26-067032
    FY 2024Yearly · 2024-12-31ProductService Unrelated To OCSTransplant4,400,000USD0001193125-26-067032
    FY 2024Yearly · 2024-12-31ProductServices167,674,000USD0001193125-26-067032
    Q3 2024Quarterly · 2024-09-30ProductProduct65,861,000USD0001193125-25-256377
    Q3 2024Quarterly · 2024-09-30ProductServices42,900,000USD0001193125-25-256377
    Q2 2024Quarterly · 2024-06-30ProductProduct71,732,000USD0000950170-25-100314
    Q2 2024Quarterly · 2024-06-30ProductService Unrelated To OCSTransplant1,100,000USD0000950170-25-100314
    Q2 2024Quarterly · 2024-06-30ProductServices42,573,000USD0000950170-25-100314
    FY 2023Yearly · 2023-12-31ProductProduct176,069,000USD0001193125-26-067032
    FY 2023Yearly · 2023-12-31ProductServices65,554,000USD0001193125-26-067032
    Q2 2023Quarterly · 2023-06-30GeographyOther Countries3,518,000USD0000950170-23-038605
    Q2 2023Quarterly · 2023-06-30GeographyUnited States48,947,000USD0000950170-23-038605
    Q1 2023Quarterly · 2023-03-31GeographyOther Countries4,053,000USD0000950170-23-017909
    Q1 2023Quarterly · 2023-03-31GeographyUnited States37,501,000USD0000950170-23-017909
    FY 2022Yearly · 2022-12-31ProductProduct79,234,000USD0000950170-25-029104
    FY 2022Yearly · 2022-12-31ProductServices14,225,000USD0000950170-25-029104
    Q4 2022Quarterly · 2022-12-31GeographyOther Countries2,321,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31GeographyUnited States29,054,000USDLegacy provider
    FY 2022Yearly · 2022-12-31GeographyOther Countries9,421,000USD0000950170-23-004652
    FY 2022Yearly · 2022-12-31GeographyUnited States84,038,000USD0000950170-23-004652
    Q3 2022Quarterly · 2022-09-30GeographyOther Countries2,398,000USD0001564590-22-036772
    Q3 2022Quarterly · 2022-09-30GeographyUnited States23,285,000USD0001564590-22-036772
    Q2 2022Quarterly · 2022-06-30GeographyOther Countries2,383,000USD0000950170-23-038605
    Q2 2022Quarterly · 2022-06-30GeographyUnited States18,138,000USD0000950170-23-038605
    Q1 2022Quarterly · 2022-03-31GeographyOther Countries2,319,000USD0000950170-23-017909
    Q1 2022Quarterly · 2022-03-31GeographyUnited States13,561,000USD0000950170-23-017909
    FY 2021Yearly · 2021-12-31ProductOcs Heart Product17,683,000USD0001564590-22-008045
    FY 2021Yearly · 2021-12-31ProductOcs Liver Product1,914,000USD0001564590-22-008045
    FY 2021Yearly · 2021-12-31ProductOcs Lung Product10,665,000USD0001564590-22-008045
    Q4 2021Quarterly · 2021-12-31GeographyOther Countries2,434,000USDLegacy provider
    Q4 2021Quarterly · 2021-12-31GeographyUnited States7,234,000USDLegacy provider
    FY 2021Yearly · 2021-12-31GeographyOther Countries8,401,000USD0000950170-23-004652
    FY 2021Yearly · 2021-12-31GeographyUnited States21,861,000USD0000950170-23-004652
    Q3 2021Quarterly · 2021-09-30GeographyNon Us And Uk1,901,000USD0001564590-21-055805
    Q3 2021Quarterly · 2021-09-30GeographyUnited Kingdom357,000USD0001564590-21-055805
    Q3 2021Quarterly · 2021-09-30GeographyUnited States3,112,000USD0001564590-21-055805
    FY 2020Yearly · 2020-12-31ProductOcs Heart Product14,196,000USD0001564590-22-008045
    FY 2020Yearly · 2020-12-31ProductOcs Liver Product5,249,000USD0001564590-22-008045
    FY 2020Yearly · 2020-12-31ProductOcs Lung Product6,194,000USD0001564590-22-008045
    FY 2020Yearly · 2020-12-31GeographyOther Countries6,400,000USD0000950170-23-004652
    FY 2020Yearly · 2020-12-31GeographyUnited States19,239,000USD0000950170-23-004652
    FY 2019Yearly · 2019-12-31ProductOcs Heart Product11,442,000USD0001564590-21-012527
    FY 2019Yearly · 2019-12-31ProductOcs Liver Product3,498,000USD0001564590-21-012527
    FY 2019Yearly · 2019-12-31ProductOcs Lung Product8,664,000USD0001564590-21-012527
    FY 2018Yearly · 2018-12-31ProductOcs Heart Product5,956,000USD0001564590-20-011409
    FY 2018Yearly · 2018-12-31ProductOcs Liver Product1,983,000USD0001564590-20-011409
    FY 2018Yearly · 2018-12-31ProductOcs Lung Product5,078,000USD0001564590-20-011409

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.